Ulrika Edvardsson

546 total citations
8 papers, 450 citations indexed

About

Ulrika Edvardsson is a scholar working on Molecular Biology, Physiology and Epidemiology. According to data from OpenAlex, Ulrika Edvardsson has authored 8 papers receiving a total of 450 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 5 papers in Physiology and 2 papers in Epidemiology. Recurrent topics in Ulrika Edvardsson's work include Peroxisome Proliferator-Activated Receptors (7 papers), Metabolism, Diabetes, and Cancer (5 papers) and Adipose Tissue and Metabolism (5 papers). Ulrika Edvardsson is often cited by papers focused on Peroxisome Proliferator-Activated Receptors (7 papers), Metabolism, Diabetes, and Cancer (5 papers) and Adipose Tissue and Metabolism (5 papers). Ulrika Edvardsson collaborates with scholars based in Sweden and United Kingdom. Ulrika Edvardsson's co-authors include Björn Dahllöf, Anna Ljungberg, Jan Oscarsson, Bengt Ljung, Daniel Lindén, Krister Bamberg, Helena Brockenhuus von Löwenhielm, Ann‐Christin Nyström, Fredrik Nilsson and Peter Åkerblad and has published in prestigious journals such as Journal of Biological Chemistry, Biochemical and Biophysical Research Communications and Journal of Lipid Research.

In The Last Decade

Ulrika Edvardsson

8 papers receiving 436 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ulrika Edvardsson Sweden 6 292 148 123 90 72 8 450
N. Lysenko United States 8 413 1.4× 94 0.6× 93 0.8× 106 1.2× 59 0.8× 12 560
Chen-Yi Lin United States 9 287 1.0× 129 0.9× 240 2.0× 154 1.7× 222 3.1× 11 626
W.J. Vaartjes Netherlands 15 373 1.3× 137 0.9× 189 1.5× 105 1.2× 116 1.6× 27 649
Nicholas B. Vera United States 7 255 0.9× 250 1.7× 126 1.0× 64 0.7× 76 1.1× 10 577
Ilse Duivenvoorden Netherlands 8 178 0.6× 57 0.4× 59 0.5× 51 0.6× 96 1.3× 9 355
Carrie A. Millward United States 9 203 0.7× 125 0.8× 124 1.0× 48 0.5× 66 0.9× 9 457
Ludvig N.W. Daae Norway 10 370 1.3× 89 0.6× 137 1.1× 242 2.7× 56 0.8× 15 624
Kathrin A. Zierler Austria 9 320 1.1× 67 0.5× 238 1.9× 279 3.1× 77 1.1× 9 542
Alexandra Rogue France 10 280 1.0× 146 1.0× 74 0.6× 41 0.5× 55 0.8× 15 557
Britta Landin Sweden 13 190 0.7× 34 0.2× 80 0.7× 110 1.2× 55 0.8× 31 514

Countries citing papers authored by Ulrika Edvardsson

Since Specialization
Citations

This map shows the geographic impact of Ulrika Edvardsson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ulrika Edvardsson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ulrika Edvardsson more than expected).

Fields of papers citing papers by Ulrika Edvardsson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ulrika Edvardsson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ulrika Edvardsson. The network helps show where Ulrika Edvardsson may publish in the future.

Co-authorship network of co-authors of Ulrika Edvardsson

This figure shows the co-authorship network connecting the top 25 collaborators of Ulrika Edvardsson. A scholar is included among the top collaborators of Ulrika Edvardsson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ulrika Edvardsson. Ulrika Edvardsson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Edvardsson, Ulrika, Anna Ljungberg, & Jan Oscarsson. (2005). Insulin and oleic acid increase PPARγ2 expression in cultured mouse hepatocytes. Biochemical and Biophysical Research Communications. 340(1). 111–117. 27 indexed citations
2.
Edvardsson, Ulrika, Anna Ljungberg, Daniel Lindén, et al.. (2005). PPARα activation increases triglyceride mass and adipose differentiation-related protein in hepatocytes. Journal of Lipid Research. 47(2). 329–340. 78 indexed citations
3.
Améen, Caroline, Ulrika Edvardsson, Anna Ljungberg, et al.. (2004). Activation of Peroxisome Proliferator-activated Receptor α Increases the Expression and Activity of Microsomal Triglyceride Transfer Protein in the Liver. Journal of Biological Chemistry. 280(2). 1224–1229. 110 indexed citations
4.
Edvardsson, Ulrika, et al.. (2003). Hepatic protein expression of lean mice and obese diabetic mice treated with peroxisome proliferator‐activated receptor activators. PROTEOMICS. 3(4). 468–478. 56 indexed citations
5.
Edvardsson, Ulrika, Helena Brockenhuus von Löwenhielm, Ann‐Christin Nyström, et al.. (1999). A proteome analysis of livers from obese (ob/ob) mice treated with the peroxisome proliferator WY14,643. Electrophoresis. 20(4-5). 935–942. 56 indexed citations
6.
Edvardsson, Ulrika, Helena Brockenhuus von Löwenhielm, Ann‐Christin Nyström, et al.. (1999). A proteome analysis of livers from obese (ob/ob) mice treated with the peroxisome proliferator WY14,643. Electrophoresis. 20(4-5). 935–942. 5 indexed citations
7.
Edvardsson, Ulrika, et al.. (1999). Rosiglitazone (BRL49653), a PPARγ-selective agonist, causes peroxisome proliferator-like liver effects in obese mice. Journal of Lipid Research. 40(7). 1177–1184. 116 indexed citations
8.
Hörnfeldt, A.‐B., et al.. (1996). 4-Substituted 1-(2-methylphenyl)thieno[2,3-c]-1,5-naphthyridines as possible reversible inhibitors of gastric H+,K+-ATPase. European Journal of Medicinal Chemistry. 31(5). 411–416. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026